Trial Profile
Does Xyrem Influence Brain Dopamine in Patients With Narcolepsy? A PET Imaging Investigation
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Sodium oxybate (Primary)
- Indications Cataplexy; Narcolepsy
- Focus Pharmacodynamics
- 23 Jan 2020 Status changed from recruiting to completed.
- 30 Jul 2019 Planned End Date changed from 1 Aug 2019 to 1 Aug 2020.
- 30 Jul 2019 Planned primary completion date changed from 1 May 2019 to 1 Mar 2020.